Literature DB >> 18551048

ABO-incompatible living donor liver transplantation: new insights into clinical relevance.

Naoki Kawagishi1, Susumu Satomi.   

Abstract

Short-term outcome of the ABO-incompatible liver transplantation has been improved dramatically due to novel immnosuppressive protocols and apheresis. This review will discuss current understanding of the clinical relevance of ABO-incompatible liver transplantation including long-term outcome mainly from the Japanese experience.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18551048     DOI： 10.1097/TP.0b013e318173a70e

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Dual liver transplantation.

Authors:  Hao Chen; Ying Zhang; Yong-mei Han; Emmanue Huguet; Dong-sheng Huang; Jia-hong Dong
Journal:  J Zhejiang Univ Sci B       Date:  2013-03       Impact factor: 3.066

Review 2.  ABO-compatible liver allograft antibody-mediated rejection: an update.

Authors:  Anthony J Demetris; Adriana Zeevi; Jacqueline G O'Leary
Journal:  Curr Opin Organ Transplant       Date:  2015-06       Impact factor: 2.640

Review 3.  Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.

Authors:  Arno Kornberg
Journal:  World J Hepatol       Date:  2015-06-18

Review 4.  Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation.

Authors:  Jongwook Oh; Jong Man Kim
Journal:  Clin Mol Hepatol       Date:  2019-03-26

5.  Blood Group Antigen Expression in Isolated Human Liver Cells in Preparation for Implementing Clinical ABO-Incompatible Hepatocyte Transplantation.

Authors:  Kazuaki Tokodai; Makiko Kumagai-Braesch; Ahmad Karadagi; Helene Johansson; Nils Ågren; Carl Jorns; Bo-Göran Ericzon; Ewa Ellis
Journal:  J Clin Exp Hepatol       Date:  2019-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.